Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2554-2558

  Reynes, Jacques ^a   Bazin, Claude ^b   Ajana, Faiza ^c   Datry, Annick ^d   Le Moing, Jean Pierre ^e   Chwetzoff, Elisabeth ^e   Levron, Jean Claude ^e  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c CENTRE HOSPITALIER DE TOURCOING   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Janssen Research Foundation   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; ATENOLOL; BROMAZEPAM; CLONAZEPAM; COTRIMOXAZOLE; DIDANOSINE; DOMPERIDONE; FLUOXETINE; FOLINIC ACID; FOSCARNET SODIUM; HYDROXYITRACONAZOLE; HYDROXYZINE; ITRACONAZOLE; LOPERAMIDE; MIANSERIN; OXACILLIN; PARACETAMOL; PAROMOMYCIN; PENFLURIDOL; PRAZEPAM; PREDNISOLONE; PYRIMETHAMINE; ZIDOVUDINE; ZOLPIDEM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOUTH INFECTION; MYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THRUSH; VIRUS INFECTION;

EID: 0030671390     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2554     Document Type: Article

References (15)

1. Barone, J. A., J. G. Koh, R. H. Bierman, J. L. Colaizzi, K. A. Swanson, M. C. Gaffar, B. L. Moskovitz, W. Mechlinski, and V. Van De Velde. 1993. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob. Agents Chemother. 37:778-784.
2. Boogaerts, M. A., G. E. Verhoef, P. Zachee, H. Demuynck, L. Verbist, and K. De Beule. 1989. Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses 32(Suppl. 1):103-108.
3. Hardin, T. C., J. R. Graybill, R. Fetchick, R. Woestenborghs, M. G. Rinaldi, and J. G. Kuhn. 1988. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob. Agents Chemother. 32:1310-1313.
4. Heykants, J., A. Van Peer, V. Van De Velde, P. Van Rooy, W. Meuldermans, K. Lavrijsen, R. Woestenborghs, J. Van Custsem, and G. Cauwenbergh. 1989. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 32(Suppl. 1):67-87.
5. Hostetler, J. S., L. H. Hanson, and D. A. Stevens. 1992. Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob. Agents Chemother. 36:477-480.
6. Lake-Bakaar, G., E. Quadros, S. Beidas, M. Elsakr, W. Tom, D. E. Wilson, H. P. Dincsoy, P. Cohen, and E. W. Straus. 1988. Gastric secretory failure in patients with the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 109:502-504.
7. Lim, S. G., A. M. Sawyerr, M. Hudson, J. Sercombe, and R. E. Pounder. 1993. Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity. Aliment. Pharmacol. Ther. 7:317-321.
8. Prentice, A. G., D. W. Warnock, S. A. N. Johnson, M. J. Phillips, and D. A. Oliver. 1994. Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplants recipients. J. Antimicrob. Chemother. 34:247-252.
9. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry for the Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
10. Saag, M. S., and W. E. Dismukes. 1988. Azole antifungal agents: emphasis on new triazoles. Antimicrob. Agents Chemother. 32:1-8.
11. Smith, D. E., J. Midgley, M. Allan, G. M. Connolly, and B. G. Gazzard. 1991. Itraconazole versus ketoconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. AIDS 5:1367-1371.
12. Smith, D., V. Van De Velde, R. Woestenborghs, and B. G. Gazzard. 1992. The pharmacokinetics of oral itraconazole in AIDS patients. J. Pharm. Pharmacol. 44:618-619.
13. Tricot, T., E. Joosten, M. A. Boogaerts, J. Vande Pitte, and G. Cauwenbergh. 1987. Ketoconazole vs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev. Infect. Dis. 9(Suppl. 1):94-99.
14. Welage, L. S., P. L. Carver, S. Revankar, C. Pierson, and C. A. Kauffman. 1995. Alterations in gastric acidity in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 21:1431-1438.
15. Woestenborghs, R., W. Lorreyne, and J. Heykants. 1987. Determination of itraconazole in plasma and animal tissues by high performance liquid chromatography. J. Chromatogr. 413:332-337.